Skip to main content

Month: August 2023

No. 9 2023 Q2 EBITDA of DKK 214m on par with expectations

Q2 revenue and EBITDA are in line with our expectations. We confirm our 2023 revenue guidance of DKK 13,500m and EBITDA guidance of DKK 900m.CEO Jens Andersen says:“Our Q2 results are on par with our expectations. When adjusted for one-off price effects, the underlying EBITDA was in line with Q2 2022, and the EBITDA margin increased slightly. Climate & Energy delivered strong growth rates, corresponding to revenue of almost DKK 375m, even though the slowdown in Denmark seen in March continued in Q2. We expect sales of heat pumps in Denmark to pick up when the new subsidy scheme is implemented, which is expected in late Q3. The measures we introduced in Q1, including cost containment, process improvements and staff reduction, became effective in Q2 and contributed to our Q2 results being in line with expectations. We confirm...

Continue reading

Boreo Plc, HALF-YEAR REPORT JAN. 1 TO JUN. 30, 2023

Boreo Plc, HALF-YEAR REPORT JAN. 1 TO JUN. 30, 2023 August 10, 2023, at 9:00 EEST Moderate profitability and strong cash flow April-June 2023Net sales grew by 5% to EUR 42.3 million (2022: 40.4). Operational EBIT increased by 1% to EUR 2.4 million (2022: 2.4), and was 5.6% of net sales. EBIT decreased by 5% to EUR 1.7 million (2022: 1.8). The profit for the period under review totaled EUR 1.0 million (2022: 1.1). Net cash flow from operating activities was EUR 3.9 million (2022: -1.9 including operations discontinued in 2022). Operational EPS was EUR 0.39 (2022: 0.44). EPS was EUR 0.18 (2022: 0.28). On June 8, 2023, Boreo announced that it had signed a share and purchase agreement concerning the acquisition of a health technology company Delfin Technologies Oy.January-June 2023Net sales grew by 15% to EUR 83.3 million (2022: 72.1). Operational...

Continue reading

Harvia’s Half-year financial review 1 January – 30 June 2023

Harvia Plc, Half-year financial review 10 August 2023 at 9.00 a.m. EESTHarvia H1 2023: Solid profitability maintained, challenging market conditions continued to impact revenue This release is a summary of Harvia Plc’s Half-year financial review January–June 2023. The complete report is attached to this release as a pdf file. It is also available on Harvia’s website at https://harviagroup.com/.   Highlights of the review period April–June 2023:Revenue decreased by 22.3% to EUR 35.8 million (46.0). At comparable exchange rates, revenue decreased by 21.3% to EUR 36.2 million. Organic revenue growth was -17.8%. Operating profit was EUR 7.8 million (8.7), making up 21.9% (19.0) of the revenue. Adjusted operating profit reached EUR 8.0 million (8.8), making up 22.3% (19.1) of the revenue. At comparable exchange rates, the adjusted operating...

Continue reading

IDEX Biometrics ASA interim report for the first half of 2023

Oslo, Norway – 10 August 2023 – IDEX Biometrics ASA’s interim report for the first half of 2023 is attached to this notice (link below). The interim report is also available on the IDEX Biometrics website: www.idexbiometrics.com/investors/interim-results/ WebcastA webcast presentation of the interim report will be held by Vince Graziani, Chief Executive Officer, today, 10 August 2023, at 09:00 CET. The webcast presentation can be viewed at the following link:                 https://channel.royalcast.com/landingpage/hegnarmedia/20230810_7/The presentation slides are attached to this notice (link below). Commercial UpdateIDEX Biometrics continues its positive momentum in the second quarter of 2023. Global demand for secure identity solutions in a digital world is increasing exponentially, driving demand for biometric technologies....

Continue reading

Eurocastle Releases First Half 2023 Financial Results

EUROCASTLE INVESTMENT LIMITED                                       Contact:        Oak Fund Services (Guernsey) LimitedCompany AdministratorAttn: Hannah CrockerTel: +44 1481 723450         Eurocastle Releases First Half 2023 Financial Results Guernsey, 10 August 2023 – Eurocastle Investment Limited (Euronext Amsterdam: ECT) today has released its interim management statement for the quarter ended 30 June 2023.ADJUSTED NET ASSET VALUE (“NAV”)1 of €10.2 million, or €10.25 per share2, down €0.09 per share vs. Q1 2023 mainly due to minor valuation adjustments to its liquidating real estate fund investments.                             Q1 2023   Q2 Cash Movement   Q2 FV Movement   Q2 2023 NAV    €’m € p.s.   €’m € p.s.   €’m € p.s.   €’m € p.s.Real Estate Funds   0.64 0.64   (0.5) (0.5)   (0.06) (0.06)   0.08 0.08Net...

Continue reading

Caledonia Mining Corporation Plc: Results for the Quarter ended June 30, 2023

ST HELIER, Jersey, Aug. 10, 2023 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (“Caledonia” or the “Company”) (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) announces its operating and financial results for the quarter and the six months ended June 30, 2023 (the “Quarter” and “First Half” respectively). Further information on the financial and operating results for the Quarter and First Half can be found in the management discussion and analysis (“MD&A”) and the unaudited financial statements which are available on the Company’s website and on SEDAR. Financial Summary for the QuarterGross revenues of $37.0 million compared to $37.09 million achieved in the second quarter of 2022 (“Q2 2022”). Gross profit of $10.9 million (Q2 2022: $17.9 million). Whilst Blanket Mine (“Blanket”) contributed $13.1 million, the group’s...

Continue reading

ADDITIONAL ROODMICROTEC WARRANT HOLDER GIVES IRREVOCABLE COMMITMENT TO SELL AND ASSIGN ITS WARRANTS UNDER THE OFFER BY MICROTEST ANNOUNCED ON 13 JUNE 2023

This is a joint press release by RoodMicrotec N.V. (“RoodMicrotec“ and, together with its subsidiaries, the “RoodMicrotec Group“) and Microtest S.p.A. (“Microtest“), an entity incorporated under Italian law, controlled by Seven Holding 3 S.à r.l., a wholly owned subsidiary of the private equity fund Xenon (as defined below), pursuant to the provisions of Section 4 Paragraph 3 and Section 5 Paragraphs 4 and 5 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen Wft, the “Decree“) in connection with the announced recommended public offer by Microtest for all the issued and outstanding ordinary shares in the capital of RoodMicrotec (the “Offer“). This press release does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities....

Continue reading

Novo Nordisk’s sales increased by 29% in Danish kroner and by 30% at constant exchange rates to DKK 107.7 billion in the first six months of 2023

Financial report for the period 1 January 2023 to 30 June 2023, 10 August 2023                                                                                                                                                                   Operating profit increased by 30% in Danish kroner and by 32% at constant exchange rates (CER) to DKK 48.9 billion. Sales in North America Operations increased by 45% in Danish kroner (44% at CER). Sales in International Operations increased by 14% in Danish kroner (17% at CER). Sales within Diabetes and Obesity care increased by 36% in Danish kroner to DKK 99.0 billion (37% at CER), mainly driven by GLP-1 diabetes sales growth of 49% in Danish kroner (50% at CER) and Obesity care growing by 158% in Danish Kroner to DKK 18.1 billion (157% at CER) . Rare disease sales decreased by 18% in both Danish...

Continue reading

ForFarmers N.V.: ForFarmers 2023 first-half results

Lochem, 10 August 2023 ForFarmers 2023 first-half resultsResults highlight importance of revised strategy and cost savings Commenting on the 2023 first-half results ForFarmers CEO Pieter Wolleswinkel said:   “The sharp decline in the result in the first six months of 2023 underlines the importance of the revised strategy, which is decisively being  implemented during this transitional year. Price competition increased amid volatile market conditions, putting further pressure on our volumes and thus also on our gross profit. The answer to this challenge lies in implementing the strategy, in which local responsibility with commercial flexibility and a differentiated approach is key. The reorganisation that this requires is being implemented this year. The outcome is a given: fewer management positions and short lines to the customer. Feed...

Continue reading

Premium Cosmetics Market to Surpass 187.22 Billion by 2030 Drives Due to the Rising Obesity

SkyQuest projects that the premium cosmetics market will attain a value of USD 187.22 billion by 2030, with a CAGR of 6.14% over the forecast period (2023-2030). The premium cosmetics market is experiencing a surge in demand, primarily driven by the increasing consumer preference for natural and organic products. In response to this demand, premium cosmetics brands are reshaping their strategies to cater to consumer expectations by offering high-quality products at competitive prices. Westford, USA, Aug. 09, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, social media has emerged as a powerful platform for obtaining information about new products and making informed purchasing decisions as consumer behaviour evolves. As a result, consumers are actively turning to social media channels to discover new products, gather product information,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.